title: The 2000 EBCTCG overview: a widening gap.
authors.affiliation: British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada. kgelmon@bccancer.bc.ca
authors.forename: S
authors.initials: S
authors.lastname: Chia
authors.forename: C
authors.initials: C
authors.lastname: Bryce
authors.forename: K
authors.initials: K
authors.lastname: Gelmon
mesh_terms: D000368:Aged; D018943:Anthracyclines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D010052:Ovariectomy; D010053:Ovary / Q000528:radiation effects; D011960:Receptors, Estrogen / Q000032:analysis; D015996:Survival Rate; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D013629:Tamoxifen